HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$14.59
Day range
$14.51 - $15.19
Year range
$12.95 - $25.47
Market cap
1.33B USD
Avg Volume
684.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 31.00M | -8.82% |
Operating expense | 334.00M | 18.02% |
Net income | -81.00M | -20.90% |
Net profit margin | -261.29 | -32.59% |
Earnings per share | -1.08 | -16.13% |
EBITDA | -88.00M | -20.55% |
Effective tax rate | -1.25% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 759.00M | -24.78% |
Total assets | 1.10B | -18.59% |
Total liabilities | 633.00M | -7.99% |
Total equity | 462.00M | — |
Shares outstanding | 90.86M | — |
Price to book | 2.38 | — |
Return on assets | -19.90% | — |
Return on capital | -37.08% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -81.00M | -20.90% |
Cash from operations | -88.00M | -25.71% |
Cash from investing | 28.00M | -40.43% |
Cash from financing | 3.00M | -72.73% |
Net change in cash | -57.00M | -375.00% |
Free cash flow | -48.88M | -125.05% |
About
Founded
2015
Website
Employees
577